Melanoma is an aggressive and potentially deadly form of skin cancer that often resists standard treatments. Recent advances in immunotherapy—using the body’s own immun...

Surgical removal of early melanomas has a high survival rate of 98%, but metastasis, the spread of cancer to other sites in the body, brings that survival rate down to 50%....

Primary melanoma tumors can have small nests of cancer cells called “microsatellites” neighboring the primary tumor. The presence of microsatellitosis has been ...

Metastatic melanoma remains a significant cause of death in the United States, with average survival rates below 35% just 5 years after initial diagnosis. In order to impro...

When melanoma is not found early, it can get into your blood and lymphatic systems and spread to other parts of your body. When this happens, the melanoma is considered met...

Objectives: Our main goal is to understand how demographic factors influence the medical care patterns of individuals diagnosed with malignant melanoma. We also aim to see ...

Metastatic melanoma is the most aggressive and deadliest type of skin cancer. Over the past decades, new therapies targeting mutations in these tumors have been developed. ...

Despite being the second most common group in the U.S. to be diagnosed with melanoma after non-Hispanic whites, Hispanics have significantly more-advanced-stage diagnoses a...

Background Explained: Utah has the highest incidence of melanoma per 100,000 individuals in the United States. While fewer people from minority communities such as Native A...

Melanoma is a tragic disease that is further complicated because scientists do not completely understand the causes, and this prevents clinicians from giving the most accur...